Discover the detailed record of transactions filed by 이강주, Chief Executive Officer. Director active across 2 companies, notably 광동제약. In total, 10 filings have been published. The latest transaction was filed on 27 February 2026 — Purchase. Regulator: DART (FSS). All data is free.
Lee Kang-joo is an Executive Director at Kwangdong Pharmaceutical, where he is responsible for managing operations and the company's strategy. His experience in the pharmaceutical sector allows him to effectively lead his team and ensure product quality.